Light Chain Bioscience (Switzerland)

Light Chain Bioscience (Switzerland)

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Light Chain Bioscience (Switzerland), Switzerland, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

61%


Total
Publications

302


Total Open
Publications

185


Total
Citations

16K


Open Access
Percentage

61%


Total
Publications

302


Total Open
Publications

185


Total
Citations

16K

Wikipedia

Website

download

Breakdown

21% 36% 4% 39%

Publisher Open

21%

Both

36%

Other Platform Open

4%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820222426Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

57%OA Journal

OA Journal 57%

97

Hybrid 10%

17

No Guarantees 33%

57

Other Platform Open

Domain 77%

94

Institution 29%

35

Other Internet 24%

29

Public 4%

5

Preprint 3%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
92
DOI
Other Internet
31
Europe PMC
Domain
8
ETH Zurich
Institution
6
Royal Netherlands Academy of Arts and Sciences
Institution
5
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
4
Figshare
Public
4
bioRxiv
Preprint
4
uniroma1.it OAI-PMH Repository
Institution
3
University of Geneva
Institution
2
1 / 4

Data updated 18 August 2025

Share

Share

Share